The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive YAZ in healthy Chinese women.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
675
20ug ethinylestradiol, 3mg drospirenone, tablet, orally, opd
Unnamed facility
Guangzhou, Guangdong, China
Unnamed facility
Guangzhou, Guangdong, China
Unnamed facility
Wuhan, Hubei, China
The primary efficacy variable is the number of unintended pregnancies as measured by the Pearl Index (PI) during 13 cycles of treatment.
Time frame: 13 cycles (1 cycle= 28 days)
Bleeding pattern indices
Time frame: 13 cycles
Cycle control parameters
Time frame: 13 cycles
Adverse events
Time frame: Whole study period
Laboratory tests
Time frame: Whole study period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Nanjing, Jiangsu, China
Unnamed facility
Nanjing, Jiangsu, China
Unnamed facility
Yangzhou, Jiangsu, China
Unnamed facility
Shenyang, Liaoning, China
Unnamed facility
Jinan, Shandong, China
Unnamed facility
Xi’an, Shanxi, China
Unnamed facility
Chengdu, Sichuan, China
...and 7 more locations